Somatic Test
prev next

TARGT IndiegeneTM Pro


A combined NGS approach of using Solid and Liquid Biopsy to gain Optimal Disease Resolution. line
4baseCare has indigenously developed and clinically validated TARGT IndiegeneTM Pro. This comprehensive test is derived from high throughput Next-generation sequencing across different solid cancer types, constituting a comprehensive core list of 1212 cancer-related genes. line
The test provides a combined NGS analysis of Tissue (Solid biopsy), ctDNA (Liquid biopsy), and the patient's Whole blood sample (gDNA). Analyzing these three sample sources identifies true somatic variants and provides a complete understanding of the patient's disease genomic landscape, which overcomes the limitations of tumor heterogeneity. line

Benefits of TARGT IndiegeneTM Pro Gene Panel Testing

Clinically Actionable Insights

This gene panel provides oncologists with clinically actionable insights from individual patients’ tumor tissue. The detailed genetic information obtained through this gene panel testing allows oncologists to make informed treatment decisions.

Identification of Novel Fusion Partners

This gene panel includes common and rare gene fusions and identifies novel fusion partners. This aspect of the gene panel testing is particularly valuable as it expands the understanding of fusion events in cancer, potentially uncovering new therapeutic targets or diagnostic markers that were previously unknown.

Inclusion of Immunotherapy Biomarkers

This gene panel goes beyond genetic alterations by incorporating immunotherapy biomarkers such as tumor mutational burden (TMB), microsatellite instability (MSI), and programmed death-ligand 1 (PD-L1) expression. These biomarkers play a crucial role in predicting response to immune checkpoint inhibitors, a cancer treatment that has shown remarkable success in certain patients.

Combined NGS Approach

This gene panel utilizes a combined NGS approach that includes solid and liquid biopsy samples. This approach enhances the resolution of the disease genomic landscape by leveraging the strengths of each sample source.

Why Choose 4baseCare's TARGT IndiegeneTM Pro Cancer Gene Panel?

Comprehensive Analysis

Our Cancer Gene Panel thoroughly assesses clinically relevant genes, ensuring accurate and reliable results.

Advanced Technology

We utilize cutting-edge genomic sequencing technologies to deliver precise and detailed genetic information.

Expert Team

Our team of experienced genetic counselors and healthcare professionals will guide you through the testing process, answer your questions, and help you understand the implications of the results.

Confidentiality and Privacy

We adhere to strict privacy protocols and maintain the confidentiality of your genetic information.

loader